MEDTRONIC PLC 2023-2024 Proxy Voting Records

Description as filed by funds: Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Craig Arnold

MEDTRONIC PLC’s own tally for this item (“Elect Director: Craig Arnold”): 1,015,233,892 for, 25,512,208 against, per its Form 8-K filed October 23, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2024 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 447,674,200 for, 478,428 against, 64,765 abstained.

Showing the 25 largest of 231 asset managers. See all 231 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Scott C. Donnelly

MEDTRONIC PLC’s own tally for this item (“Elect Director: Scott C. Donnelly”): 1,018,729,273 for, 22,005,182 against, per its Form 8-K filed October 23, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2024 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 447,909,404 for, 243,224 against, 64,765 abstained.

Showing the 25 largest of 231 asset managers. See all 231 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Lidia L. Fonseca

MEDTRONIC PLC’s own tally for this item (“Elect Director: Lidia L. Fonseca”): 1,030,005,376 for, 10,764,094 against, per its Form 8-K filed October 23, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2024 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 447,084,806 for, 1,067,824 against, 64,763 abstained.

Showing the 25 largest of 231 asset managers. See all 231 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Andrea J. Goldsmith, Ph.D.

MEDTRONIC PLC’s own tally for this item (“Elect Director: Andrea J. Goldsmith, Ph.D.”): 1,037,783,355 for, 3,012,368 against, per its Form 8-K filed October 23, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2024 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 448,142,818 for, 9,813 against, 64,762 abstained.

Showing the 25 largest of 231 asset managers. See all 231 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Randall J. Hogan, III

MEDTRONIC PLC’s own tally for this item (“Elect Director: Randall J. Hogan, III”): 1,033,959,172 for, 6,777,548 against, per its Form 8-K filed October 23, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2024 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 448,142,614 for, 10,014 against, 64,765 abstained.

Showing the 25 largest of 231 asset managers. See all 231 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Gregory P. Lewis

MEDTRONIC PLC’s own tally for this item (“Elect Director: Gregory P. Lewis”): 1,038,301,912 for, 2,429,576 against, per its Form 8-K filed October 23, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2024 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 448,150,086 for, 2,542 against, 64,765 abstained.

Showing the 25 largest of 231 asset managers. See all 231 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Kevin E. Lofton

MEDTRONIC PLC’s own tally for this item (“Elect Director: Kevin E. Lofton”): 1,037,666,791 for, 3,071,498 against, per its Form 8-K filed October 23, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2024 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 448,142,813 for, 9,815 against, 64,765 abstained.

Showing the 25 largest of 231 asset managers. See all 231 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Geoffrey S. Martha

MEDTRONIC PLC’s own tally for this item (“Elect Director: Geoffrey S. Martha”): 977,213,742 for, 55,960,304 against, per its Form 8-K filed October 23, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2024 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 447,016,824 for, 1,135,540 against, 65,029 abstained.

Showing the 25 largest of 231 asset managers. See all 231 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Elizabeth G. Nabel, M.D.

MEDTRONIC PLC’s own tally for this item (“Elect Director: Elizabeth G. Nabel, M.D.”): 1,008,532,043 for, 32,262,805 against, per its Form 8-K filed October 23, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2024 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 446,152,589 for, 2,000,042 against, 64,762 abstained.

Showing the 25 largest of 231 asset managers. See all 231 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Denise M. O'Leary

MEDTRONIC PLC’s own tally for this item (“Elect Director: Denise M. O'Leary”): 933,231,586 for, 107,195,287 against, per its Form 8-K filed October 23, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2024 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 436,632,849 for, 11,519,762 against, 64,782 abstained.

Showing the 25 largest of 231 asset managers. See all 231 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Kendall J. Powell

MEDTRONIC PLC’s own tally for this item (“Elect Director: Kendall J. Powell”): 938,167,830 for, 102,221,785 against, per its Form 8-K filed October 23, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2024 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 437,687,123 for, 10,539,911 against, 64,784 abstained.

Showing the 25 largest of 231 asset managers. See all 231 in the interactive database.

Description as filed by funds: Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law; and

MEDTRONIC PLC’s own tally for this item (“6. Renewal of the Board's authority to opt out of pre-emption rights”): 1,090,829,831 for, 70,342,442 against — passed, per its Form 8-K filed October 23, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved renewal of the Board's authority to opt out of pre-emption rights.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of MEDTRONIC PLC’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Eliminate Pre-Emptive Rights” (5 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 233 asset managers below reported 436,789,682 for, 11,505,167 against, 75 abstained, 800 not voted.

Showing the 25 largest of 233 asset managers. See all 233 in the interactive database.

Description as filed by funds: Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.

MEDTRONIC PLC’s own tally for this item (“7. Authorization of the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares”): 1,107,883,517 for, 52,096,146 against — passed, per its Form 8-K filed October 23, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved authorization of the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 233 asset managers below reported 436,985,303 for, 11,310,261 against, 160 abstained.

Showing the 25 largest of 233 asset managers. See all 233 in the interactive database.

Description as filed by funds: Renewing the Board of Directors' authority to issue shares under Irish law;

MEDTRONIC PLC’s own tally for this item (“5. Renewal of the Board's authority to issue shares”): 1,145,356,737 for, 16,259,098 against — passed, per its Form 8-K filed October 23, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved renewal of the Board's authority to issue shares.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of MEDTRONIC PLC’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Renew the Board's Authority to Issue Shares Under Irish Law” (6 managers, 222,417 for).

The 229 asset managers below reported 447,792,090 for, 265,666 against, 2,051 abstained.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.

Description as filed by funds: Approving the Company's 2024 Employee Stock Purchase Plan;

MEDTRONIC PLC’s own tally for this item (“4. The Company's 2024 Employee Stock Purchase Plan”): 1,033,704,001 for, 3,320,010 against — passed, per its Form 8-K filed October 23, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved the Company's 2024 Employee Stock Purchase Plan.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 251 asset managers below reported 448,868,319 for, 67,310 against, 59,344 abstained, 75 unknown.

Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.

Description as filed by funds: Approving, on an advisory basis, the Company's executive compensation

MEDTRONIC PLC’s own tally for this item (“3. On a non-binding advisory basis, the compensation awarded to the Company's named executive officers”): 968,139,099 for, 68,905,223 against — passed, per its Form 8-K filed October 23, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved, on a non-binding advisory basis, the compensation awarded to the Company's named executive officers.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of MEDTRONIC PLC’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “COMPENSATION” (3 managers, 826 for, 83,829 against).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 222 managers: 448,357,568 for, 674,422 against, 124,060 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 1,151 managers: 985,330,642 for, 45,191,363 against, 155 withheld, 248,973 abstained, 119,056 not voted, 100,634 unknown, 767 1 year. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2024 and authorizing, in binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration;

MEDTRONIC PLC’s own tally for this item (“2. In a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2024 and authorized, in a binding vote, the Company's Board of Directors, acting through the Au”): 1,060,656,333 for, 101,691,327 against — passed, per its Form 8-K filed October 23, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders ratified, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2024 and authorized, in a binding vote, the Company's Board of Directors, acting through the Audit Committee, to set the auditor's remuneration.”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 236 asset managers below reported 440,421,165 for, 7,840,177 against, 81,460 abstained.

Showing the 25 largest of 236 asset managers. See all 236 in the interactive database.